» Articles » PMID: 28698167

Use of a Connected Glucose Meter and Certified Diabetes Educator Coaching to Decrease the Likelihood of Abnormal Blood Glucose Excursions: The Livongo for Diabetes Program

Overview
Publisher JMIR Publications
Date 2017 Jul 13
PMID 28698167
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Livongo for Diabetes Program offers members (1) a cellular technology-enabled, two-way messaging device that measures blood glucose (BG), centrally stores the glucose data, and delivers messages back to the individual in real time; (2) unlimited BG test strips; and (3) access to a diabetes coaching team for questions, goal setting, and automated support for abnormal glucose excursions. The program is sponsored by at-risk self-insured employers, health plans and provider organizations where it is free to members with diabetes or it is available directly to the person with diabetes where they cover the cost.

Objective: The objective of our study was to evaluate BG data from 4544 individuals with diabetes who were enrolled in the Livongo program from October 2014 through December 2015.

Methods: Members used the Livongo glucose meter to measure their BG levels an average of 1.8 times per day. We estimated the probability of having a day with a BG reading outside of the normal range (70-180 mg/dL, or 3.9-10.0 mmol/L) in months 2 to 12 compared with month 1 of the program, using individual fixed effects to control for individual characteristics.

Results: Livongo members experienced an average 18.4% decrease in the likelihood of having a day with hypoglycemia (BG <70 mg/dL) and an average 16.4% decrease in hyperglycemia (BG >180 mg/dL) in months 2-12 compared with month 1 as the baseline. The biggest impact was seen on hyperglycemia for nonusers of insulin. We do not know all of the contributing factors such as medication or other treatment changes during the study period.

Conclusions: These findings suggest that access to a connected glucose meter and certified diabetes educator coaching is associated with a decrease in the likelihood of abnormal glucose excursions, which can lead to diabetes-related health care savings.

Citing Articles

The dual challenge of diabesity: pathophysiology, management, and future directions.

Sindhwani R, Bora K, Hazra S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39680103 DOI: 10.1007/s00210-024-03713-4.


Artificial intelligence in the transition of allergy: a valuable tool from childhood to adulthood.

Indolfi C, Klain A, Dinardo G, Decimo F, Miraglia Del Giudice M Front Med (Lausanne). 2024; 11:1469161.

PMID: 39219791 PMC: 11363185. DOI: 10.3389/fmed.2024.1469161.


A deep learning system for predicting time to progression of diabetic retinopathy.

Dai L, Sheng B, Chen T, Wu Q, Liu R, Cai C Nat Med. 2024; 30(2):584-594.

PMID: 38177850 PMC: 10878973. DOI: 10.1038/s41591-023-02702-z.


A data-driven approach to manage type 2 diabetes mellitus through digital health: The Klivo Intervention Program protocol (KIPDM).

Oliveira C, Bolognese L, Balcells M, Aragon D, Zagury R, Nobrega C PLoS One. 2023; 18(2):e0281844.

PMID: 36827350 PMC: 9956061. DOI: 10.1371/journal.pone.0281844.


Remote glucose monitoring is feasible for patients and providers using a commercially available population health platform.

Crossen S, Romero C, Lewis C, Glaser N Front Endocrinol (Lausanne). 2023; 14:1063290.

PMID: 36817610 PMC: 9931729. DOI: 10.3389/fendo.2023.1063290.


References
1.
Bojadzievski T, Gabbay R . Patient-centered medical home and diabetes. Diabetes Care. 2011; 34(4):1047-53. PMC: 3064021. DOI: 10.2337/dc10-1671. View

2.
Hunt C . Technology and diabetes self-management: An integrative review. World J Diabetes. 2015; 6(2):225-33. PMC: 4360416. DOI: 10.4239/wjd.v6.i2.225. View

3.
. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013; 36(4):1033-46. PMC: 3609540. DOI: 10.2337/dc12-2625. View

4.
Menke A, Casagrande S, Geiss L, Cowie C . Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015; 314(10):1021-9. DOI: 10.1001/jama.2015.10029. View

5.
Allemann S, Houriet C, Diem P, Stettler C . Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin. 2009; 25(12):2903-13. DOI: 10.1185/03007990903364665. View